MYC and renal cell carcinoma: Remarkably, glutamine metabolism upregulation has been associated with MYC proto-oncogene (MYC) overexpression in RCC, inducing glutamine transporter and glutaminase (GLS) upregulation [56], followed by elevated glutamate and α-ketoglutarate levels, and lipid accumulation in RCC tumors [56].